Chlorpromazine
用于治疗精神分裂症、双相障碍及急性精神病的抗精神病药物。
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 100mg | ¥500.00 | 现货 | |
| 500mg | ¥1454.00 | 现货 |
特色产品
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
产品描述
Chlorpromazine is a member of the typical antipsychotic or neuroleptic drug class (also known as first-generation antipsychotics), used to manage and treat schizophrenia, bipolar disorder, as well as acute psychosis. Chlorpromazine exerts its antipsychotic effect by the post-synaptic blockade at the dopamine D2 receptors in the mesolimbic pathway. Also, chlorpromazine exhibits antiemetic effect by the combined blockade at dopamine D2, histamine H1, and muscarinic M1 receptors in the vomiting center, extending its indications for alleviation of nausea and vomiting. Chlorpromazine is commonly present as the hydrochloride salt in oral and injectable forms, and as the base in the suppositories.
Reference:
1. Mann SK, Marwaha R. Chlorpromazine. [Updated 2021 May 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
产品性质
| 物理外观 | Solid |
| CAS号 | 50-53-3 |
| 分子式 | C17H19ClN2S |
| 分子量 | 318.86 |
| 化学名称 | 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine |
| 溶解度 | ≥45.6 mg/mL in DMSO; ≥48.9 mg/mL in EtOH; insoluble in H2O |
| SMILES | CN(C)CCCN1c(cc(cc2)Cl)c2Sc2c1cccc2 |
| 存储条件 | -20°C |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)
IC50和靶点
| 生物活性描述 | 氯丙嗪用于治疗精神分裂症以及控制恶心和呕吐。它是多巴胺受体(D1、D2、D3 和 D4 亚型)、血清素受体(5-HT1 和 5-HT2)和组胺 H1 受体的拮抗剂。参考文献: Brain Research. 1972; 37 (1), 91 |



沪公网安备 31011002003500